Home›Stock Screener›Godavari Drugs

Godavari Drugs Share Price Today | Stock Price & Godavari Drugs Share Screener

GODAVARI Pharmaceuticals
Live Share Price BSE
₹116.70
▼ -1.35 (-1.14%)
2026-10-05 00:00:00

As of October 5, 2026, the live Godavari Drugs share price (BSE: GODAVARI) is ₹116.70, down 1.14% from the previous close, with shares trading between ₹116.20 and ₹121.90 in today's trading session, and a 52-week range of ₹70.24–₹130.15. Check GODAVARI yearly price range for the annual price range and momentum. Use the Godavari Drugs stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Godavari Drugs opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹111 and net income of ₹4, with EBITDA of ₹11, an operating margin of 9.0% and a profit margin of 3.6%.

Godavari Drugs Market Cap ₹130.38 Cr.
GODAVARI P/E Ratio (TTM) 30.98
Godavari Drugs P/B Ratio 1.66
EPS (TTM) ₹5.43
Dividend Yield -
Debt to Equity 1.23
GODAVARI 52 Week High ₹130.15
Godavari Drugs 52 Week Low ₹70.24
Operating Margin 9.00%
Profit Margin 3.60%
GODAVARI Revenue (TTM) ₹111.00
EBITDA ₹11.00
Net Income ₹4.00
Total Assets ₹200.00
Total Equity ₹76.00

Godavari Drugs Share Price Chart

Track the current stock price of Godavari Drugs with an interactive chart. Analyse GODAVARI share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Godavari Drugs stock quote in one place.

The quote of ₹116.70 sits between the 52-week low of ₹70.24 and the 52-week high of ₹130.15, and the latest session moved -1.14% from the previous close.

Godavari Drugs Company Profile - Fundamental Screener

Screen Godavari Drugs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GODAVARI shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE362C01012.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE362C01012

Godavari Drugs Balance Sheet Screener

Screen GODAVARI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹200, up from ₹143 in 2025.

Latest statistics put total assets at ₹200 and shareholder funds at ₹76, with a leverage ratio of 1.23.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 200 143 135 121 101 91 84 74 63 56
Current Assets 112 79 89 87 74 68 61 57 47 43
Fixed Assets 30 33 27 25 26 22 14 15 15 13

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 40 27 14 14 14 16 12 9 9 6
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 76 43 39 33 30 24 20 18 17 16
Share Capital 10 8 8 8 8 8 8 8 8 8
Reserves & Surplus 60 36 31 26 22 17 13 11 10 9

Godavari Drugs Income Statement Screener - Profit & Revenue Analysis

Screen Godavari Drugs income statement and profit fundamentals. Analyze GODAVARI quarterly results. Godavari Drugs reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹111 and net profit was ₹4, equal to earnings per unit of ₹5.20, at an operating margin of 9%.

In that period expenses were ₹100, interest cost ₹4 and tax ₹1. The next period listed, 2026-March, shows revenue of ₹107 and net profit of ₹4.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 111 107 114 157 160 161 123 96 84 65 76 71 55
Expenses 100 96 102 143 150 150 113 90 78 60 70 67 49

Operating Costs and Margins

EBITDA 11 11 13 14 11 12 10 6 6 5 6 5 6
Operating Profit % 9.00% 10.00% 10.00% 8.00% 6.00% 7.00% 8.00% 6.00% 7.00% 6.00% 7.00% 6.00% 11.00%
Depreciation 2 2 2 2 2 2 1 1 1 1 1 1 1
Interest 4 4 5 5 4 3 3 3 3 2 3 2 1

Profit and Earnings

Profit Before Tax 5 5 6 7 5 7 6 2 2 1 3 2 5
Tax 1 1 1 1 1 2 2 0 1 1 1 1 1
Net Profit 4 4 4 6 4 5 4 2 1 1 2 1 4
EPS 5.20 5.43 5.82 7.37 5.03 6.97 5.48 2.66 1.60 1.10 2.40 1.79 4.84

Godavari Drugs Cash Flow Screener - Liquidity Fundamentals

Screen GODAVARI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹1, and net cash flow was an inflow of ₹12.

Over the same period, investing activities used ₹26 and financing activities provided ₹37.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 1 11 18 13 11 1 6 4 4 5
Investing Activities -26 -20 -13 -9 -5 -1 -7 -2 -3 -3

Financing and Net Cash

Financing Activities 37 8 -6 -4 -6 0 0 -2 0 -2
Net Cash Flow 12 0 -1 1 1 0 0 0 1 0

Godavari Drugs Shareholding Pattern Screener

See Godavari Drugs shareholding pattern with promoter, FII, and DII holdings. Check Godavari Drugs promoter holding and ownership changes for GODAVARI on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 40.23%, foreign institutions 0.00%, domestic institutions 2.47% and the public 40.90%, spread across 7,323 shareholders.

The shareholder count was 7,323 in 2026-Mar, compared with 6,722 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 40.23% 40.23% 52.63% 52.63% 52.61% 52.61% 53.16% 53.16%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 2.47% 2.74% 0.50% 0.50% 0.50% 0.50% 0.50% 0.50%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 40.90% 42.76% 39.93% 37.09% 37.05% 36.88% 39.10% 38.96%
Other Holding 16.40% 14.28% 6.95% 9.78% 9.84% 10.01% 7.24% 7.38%
Shareholder Count 7,323 6,722 7,881 7,828 7,720 7,483 7,005 7,044

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Godavari Drugs. Godavari Drugs dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Godavari Drugs.

Godavari Drugs Stock Index Membership - Nifty & Sensex

See which indices include Godavari Drugs stock. Check GODAVARI index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Godavari Drugs is not part of any tracked indices.
Only major market indices are tracked in our system.

Godavari Drugs Market Events Screener - Corporate Actions

Get Godavari Drugs corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Godavari Drugs stock events that may affect GODAVARI share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Annual General Meeting dated September 25, 2026, with a record date of September 25, 2026.

It is followed by Quarterly Result Announcement dated August 14, 2026 and Quarterly Result Announcement dated May 27, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-25 2026-09-25 Annual General Meeting NA -14.76%
2026-08-14 2026-08-14 Quarterly Result Announcement NA -6.54%
2026-05-27 2026-05-27 Quarterly Result Announcement NA 3.74%
2026-02-12 2026-02-12 Extraordinary General Meeting NA 4.51%
2026-02-11 2026-02-11 Quarterly Result Announcement NA -4.07%
2025-11-14 2025-11-14 Quarterly Result Announcement NA 0.47%
2025-09-27 2025-09-27 Annual General Meeting NA 4.77%
2025-08-13 2025-08-13 Quarterly Result Announcement NA 4.42%
2025-05-29 2025-05-29 Quarterly Result Announcement NA -0.50%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -1.51%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -4.33%
2024-08-29 2024-08-29 Annual General Meeting NA 52.12%

Godavari Drugs Competitors Screener - Peer Stocks Comparison

Screen GODAVARI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 428,137 35.84 61,674 12.69% 11,565 36.68
Divis Laboratories 242,320 84.36 11,067 13.95% 2,568 51.70
Torrent Pharmaceuticals 179,990 84.01 13,886 20.34% 2,138 41.12
Zydus Life Science 112,628 24.88 27,658 17.64% 5,026 47.64
Cipla 107,405 32.42 29,045 2.24% 3,870 34.78
Laurus Labs 105,777 98.56 6,868 22.01% 890 58.70
Mankind Pharma 103,472 50.48 14,636 14.85% 1,938 61.75
Dr Reddys Laboratories 99,836 31.47 35,059 3.90% 4,158 53.84
Aurobindo Pharma 96,174 25.97 34,145 5.56% 3,503 50.30
Lupin 91,796 16.71 29,039 26.75% 5,356 31.59

Godavari Drugs Company Announcements - News & Reports Screener

Screen GODAVARI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 27, 2026.

The next most recent announcements are dated September 26, 2026 and September 21, 2026.

Date Update Actions
2026-09-27 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-26 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-21 Closure of Trading Window -
2026-09-03 Intimation Of Dispatch Of Physical Letters Pursuant To Regulation 36(1)(B) Of The SEBI (LODR) Regulations -
2026-09-03 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-01 Reg. 34 (1) Annual Report. -
2026-09-01 39Th AGM To Be Held On 25Th Sep 2026 At 11.00 A.M. Through Video Conferencing -
2026-09-01 38Th AGM To Be Held On 25.09.2026 - Book Closure - 19.09.2026 - 25.09.2026 (Both Days) And Evoting Cutoff Date. -
2026-09-01 Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association -
2026-08-31 Board Meeting Outcome for Outcome Of Board Meeting Held On 31.08.2026 - Alteration Of The Main Objects Clause III(A) Of The Memorandum Of Association And Approval Of Revised Notice Of The 38Th Annual General Meeting -
2026-08-17 Submission Of Statement On Deviation Or Variation In Utilisation Of Funds For The Quarter Ended 30 June 2026 -
2026-08-17 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-14 Announcement under Regulation 30 (LODR)-Allotment -
2026-08-14 Submission Of Un-Audited Standalone Financial Results For The Quarter Ended As On June 30 2026 -
2026-08-14 Board Meeting Outcome for Outcome Of Board Meeting Held On 14.08.2026 -
2026-08-11 Update on board meeting -
2026-08-10 Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results Of The Company For The Quarter Ended June 30 2026. -
2026-07-11 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-23 Closure of Trading Window -
2026-05-28 Announcement under Regulation 30 (LODR)-Newspaper Publication -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹116.70, within a 52-week range of ₹70.24 to ₹130.15. The P/E ratio is 30.98 and the P/B ratio is 1.66, with earnings per unit of ₹5.43. Market capitalisation stands at ₹130.38 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.